Complement-dependent phagocytosis of liposomes: Suppression by "stealth" lipids

Journal of Liposome Research

Volumn 2, Issue 3, 1992, Pages 383-395

  Alving, Carl R ^a   Wassef, Nabila M ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; LIPOSOME; MONOSIALOGANGLIOSIDE; PHOSPHATIDYLINOSITOL; PROSTAGLANDIN E2; SULFOGALACTOSYLSPHINGOSINE; THROMBOXANE B2;

COMPLEMENT INHIBITION; CONFERENCE PAPER; HUMAN; LIPID ANALYSIS; LIPID COMPOSITION; LIPID TRANSPORT; MACROPHAGE; MEMBRANE BINDING; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0027043185     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109209010216     Document Type: Article

References (39)

1. Serological reactions against glycolipid-sensitised liposomes in multiple sclerosis
2. Immune reactivities of antibodies against glycolipids. II. Comparative properties, using liposomes, of purified antibodies against mono-, di-, and trihexosyl ceramide haptens
3. Naturally occurring antibodies to liposomes. I. Rabbit antibodies to sphingomyelin-containing liposomes before and after immunization with unrelated antigens
4. Immune reactivities of antibodies against glycolipids. Natural antibodies
5. Naturally occurring antibodies to liposomes. II. Specificity and electrophoretic pattern of rabbit antibodies reacting with sphingomyelin-containing liposomes
6. Natural antibodies against phospholipids and liposomes in humans
7. Antiglycolipid antibodies in normal and pathologic human sera and synovial fluids
8. Lifelong administration of liposomes and lipid A in mice: Effects on longevity, antibodies to liposomes, and terminal histopathological patterns
9. Naturally-occurring autoantibodies to cholesterol in humans
10. Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs
11. Antibodies to cholesterol, cholesterol conjugates, and liposomes: Implications for atherosclerosis and autoimmunity
12. Activation of the alternative pathway of complement by microcrystalline cholesterol
13. Mechanisms of complement activation by crystalline cholesterol
14. Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position
15. Activation of the alternative pathway of human complement by liposomes
16. Activation of human complement by liposomes: serum factor requirement for alternative pathway activation
17. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes
18. Complement-dependent phagocytosis of liposomes by macrophages
19. Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen
20. Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement
21. Suppression of phagocytic function and phospholipid metabolism in macrophages by phosphatidylinositol liposomes
22. Complement-dependent phagocytosis of liposomes by macrophages: Suppressive effects of “stealth” lipids
23. Prostaglandin and thromboxane in liposomes: Suppression of the primary immune response to liposomal antigens
24. Large unilamellar liposomes with low uptake into the reticuloendothelial system
25. Stealth liposomes: Avoiding reticuloendothelial uptake
26. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors
27. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues
28. pH-sensitive, plasma-stable liposomes with relatively prolonged residence in circulation
29. Pharmacokinetics of stealth versus conventional liposomes: effect of dose
30. Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages
31. Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles
32. Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size
33. Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells. Recognition by autologous macrophages
34. The recognition of red blood cells by macrophages: Role of phosphatidylserine and possible implications of membrane phospholipid asymmetry
35. vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes
36. Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface
37. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: A kinetic study
38. Uptake of small liposomes by non-reticuloendothelial tissues
39. Membrane complement receptors specific for bound fragments of C3